纳米甲基-D-亚斯巴酸 (NMDA) 受体调节剂的多方面的抗肥胖作用:中心-外围交叉连接
Shruti Subhash Shiromwar1, Vijay R Chidrawar2, Sudarshan Singh3
1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Pulau Pinang, Malaysia.
Journal of molecular neuroscience : MN
|January 19, 2024
概括
德克斯特罗米多芬 (Dxt) 通过减少食物摄入量和身体脂肪,减少了雌性小鼠的肥胖症. 这种N-甲基-D-酸盐受体调节器还改善了血清水平和胰岛素释放,这表明对肥胖有潜在的治疗益处.
科学领域:
- 神经内分泌学神经内分泌学
- 药理学 药理学是指药理学的学科.
背景情况:
- 下丘脑调节食物摄入量和腹感,通过N-甲基-D-酸盐受体 (NMDARs) 在下丘脑神经元上表达.
- 含有孕激素的药物可以通过下丘脑机制诱导女性的肥胖和肥胖.
- 对于NMDARs在能量平衡中的精确机制,特别是在孕激素诱导的肥胖症中,需要进一步阐明.
研究的目的:
- 在雌性小鼠的孕激素诱导肥胖模型中研究NMDAR调节器的抗肥胖作用.
- 探索这些影响的潜在机制,包括对食物摄入,发热和神经化学信号的影响.
主要方法:
- 在雌性瑞士白色老鼠中,使用4周的孕激素给药诱导了肥胖.
- 鼠被用德克斯特罗梅索芬 (Dxt),米诺环素,d-阿斯巴酸或环素治疗,并与载体或西布特拉明对照进行治疗.
- 评估的参数包括食物摄入量,体重,发热,血清脂质,胰岛素,肝酶,器官体重,身体脂肪,脂肪指数,大脑血清素和组织学.
主要成果:
- 德克斯特罗梅索芬 (Dxt) 治疗显著降低了体重,食物摄入量,器官与肝脏的比率和脂肪指数.
- Dxt还增加了体温和脑中血清素水平,表明了多方面的抗肥胖作用.
- 组织学分析显示,Dxt治疗小鼠的肝脏和脏组织学有所改善,脂肪细胞大小减少.
结论:
- 德克斯特罗梅索芬 (Dxt) 在孕激素诱导的模型中表现出显著的抗肥胖作用,通过下丘脑NMDARs起作用.
- 机制包括GABAA通道的调节,抗炎和自由基清除活动,增强大脑血清激素和改善胰岛素释放.
- Dxt代表着一种潜在的治疗药物来控制肥胖,特别是在涉及荷尔蒙影响的环境中.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Regulation of Food Intake
233
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
233
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
197
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
197


